Vaccine with reduced enhancement of viral infection

Abstract

The present application generally relates to the development of a vaccine, or the production of antibodies, capable of providing improved protection against a virus associated with ADF, such as Zika, Dengue and Ebola, based on novel antigenic peptides identified using an informational spectrum …